10.98
price down icon0.72%   -0.08
after-market After Hours: 11.00 0.02 +0.18%
loading
Anavex Life Sciences Corporation stock is traded at $10.98, with a volume of 762.94K. It is down -0.72% in the last 24 hours and up +21.59% over the past month. Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.
See More
Previous Close:
$11.06
Open:
$11.2
24h Volume:
762.94K
Relative Volume:
0.87
Market Cap:
$937.38M
Revenue:
-
Net Income/Loss:
$-43.16M
P/E Ratio:
-19.96
EPS:
-0.55
Net Cash Flow:
$-29.31M
1W Performance:
-1.17%
1M Performance:
+21.59%
6M Performance:
+19.22%
1Y Performance:
+92.29%
1-Day Range:
Value
$10.77
$11.23
1-Week Range:
Value
$10.73
$11.56
52-Week Range:
Value
$4.9301
$14.44

Anavex Life Sciences Corporation Stock (AVXL) Company Profile

Name
Name
Anavex Life Sciences Corporation
Name
Phone
844-689-3939
Name
Address
630 5TH AVENUE, NEW YORK
Name
Employee
2
Name
Twitter
@anavexlifesci
Name
Next Earnings Date
2024-12-31
Name
Latest SEC Filings
Name
AVXL's Discussions on Twitter

Compare AVXL with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
AVXL
Anavex Life Sciences Corporation
10.98 948.98M 0 -43.16M -29.31M -0.55
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
459.81 120.40B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
542.52 61.30B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
320.53 41.06B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
564.59 34.29B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.55 27.09B 3.81B -644.79M -669.77M -6.24

Anavex Life Sciences Corporation Stock (AVXL) Upgrades & Downgrades

Date Action Analyst Rating Change
Dec-06-22 Downgrade Cantor Fitzgerald Overweight → Neutral
Jun-23-22 Initiated Berenberg Buy
Sep-23-21 Initiated BTIG Research Buy
Dec-16-20 Reiterated H.C. Wainwright Buy
Sep-28-20 Initiated Ladenburg Thalmann Buy
Feb-27-20 Initiated Cantor Fitzgerald Overweight
Jun-18-19 Initiated Janney Buy
May-16-18 Resumed Maxim Group Buy
Mar-08-18 Initiated ROTH Capital Buy
Feb-13-18 Reiterated Maxim Group Buy
Sep-29-17 Resumed Noble Financial Buy
Feb-07-17 Initiated Noble Financial Buy
Mar-29-16 Initiated FBR Capital Outperform
View All

Anavex Life Sciences Corporation Stock (AVXL) Latest News

pulisher
Jul 20, 2025

What drives Anavex Life Sciences Corp. stock priceRecord-breaking capital gains - PrintWeekIndia

Jul 20, 2025
pulisher
Jul 20, 2025

Anavex Life Sciences Corp. Stock Analysis and ForecastFastest return on investment - PrintWeekIndia

Jul 20, 2025
pulisher
Jul 20, 2025

What analysts say about Anavex Life Sciences Corp. stockFree Risk Assessment Services - jammulinksnews.com

Jul 20, 2025
pulisher
Jul 20, 2025

Is Anavex Life Sciences Corp. a good long term investmentFree Capital Allocation Plans - Autocar Professional

Jul 20, 2025
pulisher
Jul 15, 2025

How Anavex Life Sciences Corp. stock performs during market volatilityLow Volatility High Yield Stocks - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Anavex Life Sciences Corp. stock price move sharplyTriple Return With Stability - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Anavex Life Sciences Corp. stock attracts strong analyst attentionSafety First Trading Signals - Newser

Jul 15, 2025
pulisher
Jul 14, 2025

Anavex Life Sciences (AVXL) Files for $300 Million Stock Offerin - GuruFocus

Jul 14, 2025
pulisher
Jul 14, 2025

Anavex Life Sciences Files for $300 Million Stock Sale - MarketScreener

Jul 14, 2025
pulisher
Jul 10, 2025

Wealth Enhancement Advisory Services LLC Sells 4,045 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World

Jul 10, 2025
pulisher
Jul 03, 2025

Anavex Life Sciences extends CEO and principal financial officer contracts - Investing.com

Jul 03, 2025
pulisher
Jul 03, 2025

Anavex Life Sciences extends CEO and principal financial officer contracts By Investing.com - Investing.com UK

Jul 03, 2025
pulisher
Jul 02, 2025

Top 5 Trending Stocks On Stocktwits Today: Webull, SharpLink, Anavex Life Sciences, BigBear.ai, And Oscar Health - MSN

Jul 02, 2025
pulisher
Jul 02, 2025

Cambridge Investment Research Advisors Inc. Buys 164,792 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World

Jul 02, 2025
pulisher
Jun 30, 2025

Anavex Life Sciences Corp.(NasdaqGS: AVXL) dropped from Russell Microcap Value Index - MarketScreener

Jun 30, 2025
pulisher
Jun 23, 2025

Anavex (AVXL) Sees Notable Increase in Borrow Rate | AVXL Stock News - GuruFocus

Jun 23, 2025
pulisher
Jun 18, 2025

Anavex Gets Suit Over Rett Syndrome Clinical Trials Nixed - Law360

Jun 18, 2025
pulisher
Jun 16, 2025

ANAVEX SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Anavex Life Sciences ... - Bluefield Daily Telegraph

Jun 16, 2025
pulisher
Jun 16, 2025

ANAVEX SHAREHOLDER ALERT: Kaskela Law LLC Announces - GlobeNewswire

Jun 16, 2025
pulisher
Jun 16, 2025

ANAVEX SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Anavex Life Sciences Corp. (NASDAQ: AVXL) and Encourages Long-Term Investors to Contact the Firm - GlobeNewswire Inc.

Jun 16, 2025
pulisher
Jun 16, 2025

Wealth Enhancement Advisory Services LLC Boosts Holdings in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World

Jun 16, 2025
pulisher
Jun 15, 2025

Anavex Life Sciences Corp. Appoints Ulrich Elben, as Vice President of Preclinical Operations - marketscreener.com

Jun 15, 2025
pulisher
Jun 13, 2025

Anavex Life Sciences Approves Key Amendments at Annual Meeting - TipRanks

Jun 13, 2025
pulisher
Jun 13, 2025

We're Not Worried About Anavex Life Sciences' (NASDAQ:AVXL) Cash Burn - Yahoo Finance

Jun 13, 2025
pulisher
Jun 07, 2025

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Anavex Life Sciences Corp. of Class Action Lawsuit and a Lead Plaintiff Deadline of February 29, 2016AVXL - ACCESS Newswire

Jun 07, 2025
pulisher
Jun 03, 2025

Cetera Investment Advisers Acquires New Position in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Bank of America Corp DE Sells 76,485 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Ameriprise Financial Inc. Buys 3,243 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

Millennium Management LLC Sells 133,208 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World

Jun 02, 2025
pulisher
Jun 01, 2025

Anavex Life Sciences Corp. (NASDAQ:AVXL) Stock Holdings Lessened by BNP Paribas Financial Markets - Defense World

Jun 01, 2025
pulisher
May 28, 2025

Deutsche Bank AG Has $693,000 Stock Position in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World

May 28, 2025
pulisher
May 24, 2025

D. E. Shaw & Co. Inc. Purchases Shares of 105,130 Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World

May 24, 2025
pulisher
May 19, 2025

Northern Trust Corp Raises Stake in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World

May 19, 2025
pulisher
May 18, 2025

The Manufacturers Life Insurance Company Has $298,000 Holdings in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World

May 18, 2025
pulisher
May 18, 2025

HC Wainwright Issues Positive Forecast for AVXL Earnings - Defense World

May 18, 2025
pulisher
May 17, 2025

Anavex Life Sciences Corp.'s (NASDAQ:AVXL) largest shareholders are individual investors with 60% ownership, institutions own 37% - Yahoo Finance

May 17, 2025
pulisher
May 16, 2025

Anavex Life Sciences Corp. (NASDAQ:AVXL) Shares Sold by Price T Rowe Associates Inc. MD - Defense World

May 16, 2025
pulisher
May 15, 2025

Tower Research Capital LLC TRC Buys 1,708 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World

May 15, 2025
pulisher
May 15, 2025

Does Anavex's Alzheimer's Drug Actually Confer Benefit Over Three Years? (NASDAQ:AVXL) - Seeking Alpha

May 15, 2025
pulisher
May 14, 2025

Anavex Life Sciences Corp (AVXL) Q2 2025 Earnings Call Highlight - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Anavex Life Sciences Corp (AVXL) Q2 2025 Earnings Call Highlights: Promising Alzheimer's Data ... - Yahoo Finance

May 14, 2025
pulisher
May 14, 2025

Anavex Life Sciences Corp. (NASDAQ:AVXL) Q2 2025 Earnings Call Transcript - Insider Monkey

May 14, 2025
pulisher
May 14, 2025

Anavex Life Sciences to Participate at Upcoming Healthcare Confe - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Anavex Life Sciences to Participate at Upcoming Healthcare Conferences | AVXL Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Anavex Life Sciences to Participate at Upcoming Healthcare Conferences - The Manila Times

May 14, 2025
pulisher
May 14, 2025

Anavex Brings Alzheimer's and Parkinson's Drug Updates to Prestigious Wainwright Healthcare Conferences - Stock Titan

May 14, 2025
pulisher
May 14, 2025

Anavex Life Sciences: Fiscal Q2 Earnings Snapshot - CT Insider

May 14, 2025
pulisher
May 14, 2025

Anavex Life Sciences Reports Q2 2025 Financial Results - TipRanks

May 14, 2025
pulisher
May 14, 2025

Raymond James Financial Inc. Makes New $167,000 Investment in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World

May 14, 2025

Anavex Life Sciences Corporation Stock (AVXL) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$21.88
price down icon 0.59%
$35.59
price up icon 0.34%
$102.56
price down icon 1.55%
$26.20
price down icon 5.18%
$110.02
price down icon 0.92%
biotechnology ONC
$294.55
price up icon 1.45%
Cap:     |  Volume (24h):